Evidence map›Paper›PMID 35490659›Full record

ArticleBiochemical and biophysical research communications2022

Crystal structure of SARS-CoV 3C-like protease with baicalein.

Jingwen Feng, Dongyang Li, Jin Zhang, Xiushan Yin, Jian Li

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochemical and biophysical research communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. 3CLJournal of computer-aided molecular design · 2025
    Article
  3. Inhibitory Efficacy of Main Components ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Discovery of PLACS omega · 2023
    Article
  6. Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jingwen FengApplied Biology Laboratory, College of Pharmaceutical and Biological Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China.
Dongyang LiApplied Biology Laboratory, College of Pharmaceutical and Biological Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China; College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, China.
Jin ZhangSchool of Basic Medical Sciences, Nanchang University, Nanchang, 330031, China.
Xiushan YinApplied Biology Laboratory, College of Pharmaceutical and Biological Engineering, Shenyang University of Chemical Technology, Shenyang, 110142, China.
Jian LiCollege of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, China. Electronic address: rmsl_2040@163.com.
Gannan Medical University · CNShenyang University of Chemical Technology · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 3C-like protease (M

Indexed as

Severe acute respiratory syndrome-related coronavirusAntiviral AgentsCoronavirus 3C ProteasesFlavanonesPeptide HydrolasesProtease InhibitorsSARS-CoV-2Antiviral AgentsbaicaleinCoronavirus 3C ProteasesFlavanonesPeptide HydrolasesProtease Inhibitors3C-like proteaseBaicaleinSARS-CoV

Identifiers

PMID35490659
PMCPMC9027212
OpenAlexW4224298000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.